Long-term of 10 Years Results of a Prospective Longitudinal Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

1999-11-30

Study Completion Date

2013-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Previous cross-sectional studies have demonstrated that blood pressure (BP) measurements at home (HBP) in the morning offer stronger predictive power for micro- and macrovascular complications in patients with type 1 and 2 diabetes than casual/clinic blood pressure measurements (CBP) (Kamoi K et al, 2002-2003). Further, a prospective, longitudinal study for 6 years in patients with type 2 diabetes also demonstrated that control of wakening-up HBP provides the stronger predictive power for the outcomes than that of CBP did (Kamoi et al, 2010).

However, it is not clear to show which of BP measurement provides the stronger predictive power for outcomes by comparing cumulative events over a longer time than 6 years. Therefore, the investigators examined which of HBP or CBP provides the stronger predictive power for outcomes in addition of renal anemia reported previously over 10 years in the patients with type 2 diabetes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Cohort Study of Morning Home Blood Pressure Measurement in Type 2 Diabetic Patients

NCT00760110

Hypertension Type 2 Diabetes

COMPLETED

Study of the Relationship Between Sleep Quality and Daytime-Nighttime Variations of Blood Pressure and Plasma Glucose Type I

NCT00805974

Type 1 Diabetes

TERMINATED NA

Blood Pressure Telemonitoring and Goal Blood Pressure in Diabetes

NCT01300338

Diabetes Hypertension

COMPLETED NA

Home Blood Pressure Monitoring to Improve Hypertension

NCT05604040

Hypertension

COMPLETED NA

Home Monitoring in the Management of Hypertension and Diabetes Mellitus

NCT00968786

Hypertension Type 2 Diabetes Mellitus

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Mellitus Blood Pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1. Morning HP and NT

Subjects based on HBP were divided into MH and MN patients

Blood pressure measurement based on HBP or CBP

Intervention Type PROCEDURE

To clarify which of HBP or CBP provides the stronger prediction power for the outcomes.

2. Clinic HP and NT

Subjects based on CBP were divided into CH and CN patients

Blood pressure measurement based on HBP or CBP

Intervention Type PROCEDURE

To clarify which of HBP or CBP provides the stronger predictive power for the outcomes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood pressure measurement based on HBP or CBP

To clarify which of HBP or CBP provides the stronger prediction power for the outcomes.

Intervention Type PROCEDURE

Blood pressure measurement based on HBP or CBP

To clarify which of HBP or CBP provides the stronger predictive power for the outcomes

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* After a detailed baseline examination, 400 Japanese subjects with type 2 diabetes reported previously are followed up for all-cause mortality and morbidity.